Five DEGs, including CXCL10, CD44, B2M, XRCC5, and RPL11 might be potential druggable genes for patients with LA-NPC metastasis by regulating cell cycle-related pathways. The gene discussed is B2M; the disease is nasopharyngeal carcinoma.